Speaker illustration

Mrs Rose Hamershock

Brigham and Women's Hospital, Boston (United States of America)

Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

Event: ESC Congress 2018

Topic: Biostatistics

Session: Atrial fibrillation, stroke and cardiovascular risk


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb